NOACs drive rise in AF anticoagulant use: study

The availability of novel oral anticoagulants (NOACs) has increased the use of stroke prevention therapy for AF, particularly for high-risk patients, an Australian study shows.

Rates of anticoagulation increased from 52.5% to 60.7% of patients with non-valvular AF between the pre- and post-NOAC eras, according to the study carried out at the Royal Hobart Hospital.

There was a notable increase in prescribing rates of oral anticoagulants for high-risk AF patients